Mycophenolate mofetil and curcumin provide comparable therapeutic benefit in experimental chronic kidney disease: role of Nrf2-Keap1 and renal dopamine pathways

References

• Stenvinkel P. Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease. J Intern Med 2010;268:456–467.
   PubMed Web of Science ®Google Scholar
• Brenner BM. Nephron adaptation to renal injury or ablation. Am J Physiol 1985;249:F324–F337.
   PubMed Web of Science ®Google Scholar
• Bidani AK, Polichnowski AJ, Loutzenhiser R, Griffin KA. Renal microvascular dysfunction, hypertension and CKD progression. Curr Opin Nephrol Hypertens 2013;22:1–9.
   PubMed Web of Science ®Google Scholar
• Romero F, Rodriguez-Iturbe B, Parra G, Gonzalez L, Herrera-Acosta J, Tapia E. Mycophenolate mofetil prevents the progressive renal failure induced by 5/6 renal ablation in rats. Kidney Int 1999;55:945–955.
   PubMed Web of Science ®Google Scholar
• Tapia E, Franco M, Sanchez-Lozada LG, Soto V, Avila-Casado C, Santamaria J, et al. Mycophenolate mofetil prevents arteriolopathy and renal injury in subtotal ablation despite persistent hypertension. Kidney Int 2003;63:994–1002.
   PubMed Web of Science ®Google Scholar
• Boumpas DT, Bertsias GK, Balow JE. A decade of mycophenolate mofetil for lupus nephritis: is the glass half-empty or half-full? Ann Rheum Dis 2010;69:2059–2061.
   PubMed Web of Science ®Google Scholar
• Chen Y, Li Y, Yang S, Li Y, Liang M. Efficacy and safety of mycophenolate mofetil treatment in IgA nephropathy: a systematic review. BMC Nephrol 2014;15:193.
   PubMed Web of Science ®Google Scholar
• Choi BH, Kang KS, Kwak MK. Effect of redox modulating NRF2 activators on chronic kidney disease. Molecules 2014;19:12727–12759.
   PubMed Web of Science ®Google Scholar
• Cuevas S, Villar VA, Jose PA, Armando I. Renal dopamine receptors, oxidative stress, and hypertension. Int J Mol Sci 2013;14:17553–17572.
   PubMed Web of Science ®Google Scholar
• Vaziri ND, Liu S, Farzaneh SH, Nazertehrani S, Khazaeli M, Zhao YY. Dose-dependent deleterious and salutary actions of the Nrf2 inducer dh404 in chronic kidney disease. Free Radic Biol Med 2015;86:374–381.
   PubMed Web of Science ®Google Scholar
• Jimenez-Osorio AS, Gonzalez-Reyes S, Pedraza-Chaverri J. Natural Nrf2 activators in diabetes. Clin Chim Acta 2015;448:182–192.
   PubMed Web of Science ®Google Scholar
• Gupta SC, Kismali G, Aggarwal BB. Curcumin, a component of turmeric: from farm to pharmacy. Biofactors 2013;39:2–13.
   PubMed Web of Science ®Google Scholar
• Tapia E, Sanchez-Lozada LG, Soto V, Manrique AM, Ortiz-Vega KM, Santamaria J, et al. Sildenafil treatment prevents glomerular hypertension and hyperfiltration in rats with renal ablation. Kidney Blood Press Res 2012;35:273–280.
   PubMed Web of Science ®Google Scholar
• Correa F, Buelna-Chontal M, Hernandez-Resendiz S, Garcia-Nino WR, Roldan FJ, Soto V, et al. Curcumin maintains cardiac and mitochondrial function in chronic kidney disease. Free Radic Biol Med 2013;61:119–129.
   PubMed Web of Science ®Google Scholar
• Yamagata K, Muro K, Usui J, Hagiwara M, Kai H, Arakawa Y, et al. Mitochondrial DNA mutations in focal segmental glomerulosclerosis lesions. J Am Soc Nephrol 2002;13:1816–1823.
   PubMed Web of Science ®Google Scholar
• Griffin KA, Hacioglu R, Abu-Amarah I, Loutzenhiser R, Williamson GA, Bidani AK. Effects of calcium channel blockers on “ dynamic” and “steady-state step” renal autoregulation. Am J Physiol Renal Physiol 2004;286:F1136–F1143.
   Google Scholar
• Tapia E, Cristobal M, Garcia-Arroyo FE, Soto V, Monroy-Sanchez F, Pacheco U, et al. Synergistic effect of uricase blockade plus physiological amounts of fructose-glucose on glomerular hypertension and oxidative stress in rats. Am J Physiol Renal Physiol 2013;304:F727–F736.
   Google Scholar
• Tapia E, Sanchez-Lozada LG, Garcia-Nino WR, Garcia E, Cerecedo A, Garcia-Arroyo FE, et al. Curcumin prevents maleate-induced nephrotoxicity: relation to hemodynamic alterations, oxidative stress, mitochondrial oxygen consumption and activity of respiratory complex I. Free Radic Res 2014;48:1342–1354.
   PubMed Web of Science ®Google Scholar
• Satoh M, Fujimoto S, Haruna Y, Arakawa S, Horike H, Komai N, et al. NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy. Am J Physiol Renal Physiol 2005;288:F1144–F1152.
   PubMed Web of Science ®Google Scholar
• Felder RA, Sanada H, Xu J, Yu PY, Wang Z, Watanabe H, et al. G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proc Natl Acad Sci USA 2002;99:3872–3877.
   PubMed Web of Science ®Google Scholar
• Suzuki YaR, C. Immunoprecipitation methods. In: Tomino Y, ed. Laboratory techniques in renal cell and molecular biology. Basel, Switzerland: Karger; 1997:111–115.
   Google Scholar
• Bidani AK, Griffin KA. Pathophysiology of hypertensive renal damage: implications for therapy. Hypertension 2004;44:595–601.
   PubMed Web of Science ®Google Scholar
• Fellner RC, Cook AK, O'Connor PM, Zhang S, Pollock DM, Inscho EW. High-salt diet blunts renal autoregulation by a reactive oxygen species-dependent mechanism. Am J Physiol Renal Physiol 2014;307:F33–F40.
   Google Scholar
• Sharma K, Cook A, Smith M, Valancius C, Inscho EW. TGF-beta impairs renal autoregulation via generation of ROS. Am J Physiol Renal Physiol 2005;288:F1069–F1077.
   Google Scholar
• Okamura DM, Pennathur S. The balance of powers: redox regulation of fibrogenic pathways in kidney injury. Redox Biol 2015;6:495–504.
   PubMed Web of Science ®Google Scholar
• Lee JM, Johnson JA. An important role of NRF2-ARE pathway in the cellular defense mechanism. J Biochem Mol Biol 2004;37:139–143.
   PubMedGoogle Scholar
• Itoh K, Igarashi K, Hayashi N, Nishizawa M, Yamamoto M. Cloning and characterization of a novel erythroid cell-derived CNC family transcription factor heterodimerizing with the small Maf family proteins. Mol Cell Biol 1995;15:4184–4193.
   PubMed Web of Science ®Google Scholar
• Itoh K, Wakabayashi N, Katoh Y, Ishii T, Igarashi K, Engel JD, Yamamoto M. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev1999;13:76–86.
   PubMed Web of Science ®Google Scholar
• Kobayashi A, Kang MI, Okawa H, Ohtsuji M, Zenke Y, Chiba T, et al. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol Cell Biol 2004;24:7130–7139.
   PubMed Web of Science ®Google Scholar
• Staatz CE, Tett SE. Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update. Arch Toxicol 2014;88:1351–1389.
   PubMed Web of Science ®Google Scholar
• Tapia E, Zatarain-Barron ZL, Hernandez-Pando R, Zarco-Marquez G, Molina-Jijon E, Cristobal-Garcia M, et al. Curcumin reverses glomerular hemodynamic alterations and oxidant stress in 5/6 nephrectomized rats. Phytomedicine 2013;20:359–366.
   PubMed Web of Science ®Google Scholar
• Ma Q, Battelli L, Hubbs AF. Multiorgan autoinmune inflammation, enhanced lymphoproliferation, and impaired homeostasis of reactive oxygen species in mice lacking the antioxidant-activated transcription factor Nrf2. Am J Pathol 2006;168:1960–1974.
   PubMed Web of Science ®Google Scholar
• Nguyen T, Sherratt PJ, Nioi P, Yang CS, Pickett CB. Nrf2 controls constitutive and inducible expression of ARE-driven genes through a dynamic pathway involving nucleocytoplasmic shuttling by Keap1. J Biol Chem 2005;280:32485–32492.
   PubMed Web of Science ®Google Scholar
• Bryan HK, Olayanju A, Goldring CE, Park BK. The Nrf2 cell defence pathway: Keap1-dependent and -independent mechanisms of regulation. Biochem Pharmacol 2013;85:705–717.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Vaziri ND. Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure. Am J Physiol Renal Physiol 2010;298:F662–F671.
   PubMed Web of Science ®Google Scholar
• Aminzadeh MA, Nicholas SB, Norris KC, Vaziri ND. Role of impaired Nrf2 activation in the pathogenesis of oxidative stress and inflammation in chronic tubulo-interstitial nephropathy. Nephrol Dial Transplant 2013;28:2038–2045.
   PubMed Web of Science ®Google Scholar
• Palsamy P, Ayaki M, Elanchezhian R, Shinohara T. Promoter demethylation of Keap1 gene in human diabetic cataractous lenses. Biochem Biophys Res Commun 2012;423:542–548.
   PubMed Web of Science ®Google Scholar
• Liu ZZ, Zhao XZ, Zhang XS, Zhang M. Promoter DNA demethylation of Keap1 gene in diabetic cardiomyopathy. Int J Clin Exp Pathol 2014;7:8756–8762.
   PubMed Web of Science ®Google Scholar
• Arellano-Buendia AS, Tostado-Gonzalez M, Garcia-Arroyo FE, Cristobal-Garcia M, Loredo-Mendoza ML, Tapia E, et al. Anti-Inflammatory therapy modulates nrf2-keap1 in kidney from rats with diabetes. Oxid Med Cell Longev 2016;2016:4693801.
   PubMedGoogle Scholar
• Carey RM. Theodore Cooper lecture: renal dopamine system: paracrine regulator of sodium homeostasis and blood pressure. Hypertension 2001;38:297–302.
   PubMed Web of Science ®Google Scholar
• Fung MM, Rana BK, Tang CM, Shiina T, Nievergelt CM, Rao F, et al. Dopamine D1 receptor (DRD1) genetic polymorphism: pleiotropic effects on heritable renal traits. Kidney Int 2009;76:1070–1080.
   PubMed Web of Science ®Google Scholar
• Banday AA, Lokhandwala MF. Oxidative stress reduces renal dopamine D1 receptor-Gq/11alpha G protein-phospholipase C signaling involving G protein-coupled receptor kinase 2. Am J Physiol Renal Physiol 2007;293:F306–F315.
   Google Scholar
• Asghar M, Banday AA, Fardoun RZ, Lokhandwala MF. Hydrogen peroxide causes uncoupling of dopamine D1-like receptors from G proteins via a mechanism involving protein kinase C and G-protein-coupled receptor kinase 2. Free Radic Biol Med 2006;40:13–20.
   PubMed Web of Science ®Google Scholar
• Trivedi M, Lokhandwala MF. Rosiglitazone restores renal D1A receptor-Gs protein coupling by reducing receptor hyperphosphorylation in obese rats. Am J Physiol Renal Physiol 2005;289:F298–F304.
   PubMed Web of Science ®Google Scholar
• Pakfetrat M, Akmali M, Malekmakan L, Dabaghimanesh M, Khorsand M. Role of turmeric in oxidative modulation in end-stage renal disease patients. Hemodial Int 2015;19:124–131.
   PubMed Web of Science ®Google Scholar